TWD 6.05
(-22.34%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 41.48 Million TWD | -45.96% |
2022 | 76.75 Million TWD | -37.48% |
2021 | 122.77 Million TWD | 7.46% |
2020 | 114.24 Million TWD | 5.05% |
2019 | 108.74 Million TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 10.28 Thousand TWD | -38.48% |
2024 Q2 | 10.28 Thousand TWD | 3.56% |
2023 Q4 | 16.72 Thousand TWD | 0.0% |
2023 Q3 | 16.72 Thousand TWD | 65.77% |
2023 FY | 41.48 Million TWD | -45.96% |
2023 Q2 | 10.08 Thousand TWD | 0.0% |
2023 Q1 | 10.08 Thousand TWD | -10.18% |
2022 Q3 | 11.22 Thousand TWD | 0.0% |
2022 FY | 76.75 Million TWD | -37.48% |
2022 Q4 | 11.22 Thousand TWD | 0.0% |
2021 FY | 122.77 Million TWD | 7.46% |
2020 FY | 114.24 Million TWD | 5.05% |
2019 FY | 108.74 Million TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -12508.511% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | 67.508% |
Level Biotechnology Inc. | 151.99 Million TWD | 72.708% |
Sagittarius Life Science Corp | 135.85 Million TWD | 69.466% |
NeoCore Technology Co., Ltd. | 75.85 Million TWD | 45.317% |
TaiMed Biologics Inc. | 225.23 Million TWD | 81.583% |
GlycoNex Incorporation | 995 Thousand TWD | -4069.045% |
VBI | 32.55 Million TWD | -27.421% |
GeneReach Biotechnology Corp. | 256.86 Million TWD | 83.851% |
Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 78.638% |
SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | 9.867% |
Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 65.406% |
Visgeneer Inc. | 67.48 Million TWD | 38.529% |
Mycenax Biotech Inc. | -375.19 Million TWD | 111.056% |
Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 91.868% |
G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | 35.086% |
Neith Corporation | 66.87 Million TWD | 37.969% |
Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 97.127% |
TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | -41.326% |
Enimmune corporation | 220.1 Million TWD | 81.153% |
TaiRx, Inc. | 217.13 Million TWD | 80.896% |
CHO Pharma, Inc. | 268.99 Million TWD | 84.579% |
EirGenix Inc. | 236.74 Million TWD | 82.478% |
BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 60.248% |
Sunny Pharmtech Inc. | 357.62 Million TWD | 88.401% |
Lin BioScience, Inc. | 1.09 Billion TWD | 96.218% |
BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 84.415% |
Feng Chi Biotech Corp. | 49.47 Million TWD | 16.149% |
Bio Preventive Medicine Corp. | 1.08 Million TWD | -3730.286% |
Lukas Biomedical Inc. | 177.45 Million TWD | 76.623% |
RBC Bioscience Corporation | 58.35 Million TWD | 28.916% |
BiOptic Inc. | 108.69 Million TWD | 61.835% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -45991.111% |
Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | 40.185% |
Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -1486.31% |
Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 93.558% |
Advagene Biopharma Co., Ltd. | 93.33 Million TWD | 55.556% |
NaviFUS Corp. | 11.82 Million TWD | -250.74% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 78.251% |
Sinew Pharma Inc. | 186.25 Million TWD | 77.728% |
Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | 43.961% |
Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 81.179% |
Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -0.002% |
AP Biosciences Inc | 32.25 Million TWD | -28.614% |
Medigen Biotechnology Corp. | 1.85 Billion TWD | 97.758% |
3D Global Biotech Inc. | 5.27 Million TWD | -686.538% |
Pharmosa Biopharm Inc. | 317.32 Million TWD | 86.928% |
Intech Biopharm Corporation | -163.99 Million TWD | 125.295% |
Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 96.326% |
TWi Biotechnology, Inc. | 169.55 Million TWD | 75.535% |
Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 71.785% |
TCI GENE Inc. | 174.61 Million TWD | 76.244% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -230355.556% |
Senhwa Biosciences, Inc. | 300.93 Million TWD | 86.216% |
Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 85.743% |
NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | 50.584% |
PharmaEngine, Inc. | 441.78 Million TWD | 90.61% |
Savior Lifetec Corporation | 223.36 Million TWD | 81.429% |
TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 83.97% |
OBI Pharma, Inc. | 2.01 Billion TWD | 97.943% |
Meribank Biotech Co., Ltd | 138.87 Million TWD | 70.129% |
Acepodia, Inc. | 452.56 Million TWD | 90.834% |
Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 92.331% |